Literature DB >> 12525323

[Opportunistic infections in patients with inflammatory bowel disease undergoing immunosuppressive therapy].

I Bernal1, E Domènech, E García-Planella, E Cabré, M A Gassull.   

Abstract

Immunosuppressive agents (azathioprine, methotrexate) are increasingly being used in the treatment of inflammatory bowel disease. The use of immunosuppressive agents is associated with a greater risk of opportunistic infections, the most frequent of which are those caused by cytomegalovirus and varicella zoster virus. We present four cases of opportunistic infections due to Herpesviruses in patients undergoing immunosuppressive treatment with azathioprine for Crohn's disease. We also review the literature published on this topic. Two patients presented cutaneous varicella complicated by pneumonia and esophagitis respectively, one patient had cutaneous herpes zoster and the other had fatal pneumonia possibly caused by the Herpesvirus. In the first three the clinical course of the infection was favorable after withdrawing immunosuppressant treatment and initiating treatment with aziclovir. In patients Crohn's disease azathioprine treatment increases the risk of opportunistic infection by Herpesvirus. However, in the absence of other factors that increase immunosuppression, these infections usually have a benign course with specific antiviral therapy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12525323     DOI: 10.1016/s0210-5705(03)70335-5

Source DB:  PubMed          Journal:  Gastroenterol Hepatol        ISSN: 0210-5705            Impact factor:   2.102


  11 in total

1.  Patients with inflammatory bowel disease have a lower response rate to HBV vaccination compared to controls.

Authors:  Mustafa Erhan Altunöz; Ebubekir Senateş; Atakan Yeşil; Turan Calhan; Ayşe Oya Kurdaş Ovünç
Journal:  Dig Dis Sci       Date:  2011-12-07       Impact factor: 3.199

2.  Vaccination issues in patients with inflammatory bowel disease receiving immunosuppression.

Authors:  Seper Dezfoli; Gil Y Melmed
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-08

3.  Rates and Predictors of Vaccinations Among Inflammatory Bowel Disease Patients Receiving Anti-Tumor Necrosis Factor Agents.

Authors:  Hung-Viet Pham; Imran Hasan; Natalia Udaltsova; Kathy Pham; Oren Abramson; Mary Anne Armstrong; Debbie Postlethwaite; Dan Li
Journal:  Dig Dis Sci       Date:  2017-08-23       Impact factor: 3.199

4.  Fatal rhinocerebral mucormycosis in a patient with ulcerative colitis receiving azathioprine and corticosteroid.

Authors:  Narges Najafi; Firoozeh Kermani; Nahid Gholinejad Ghadi; Seyed Reza Aghili; Zahra Seifi; Emmanuel Roilides; Tahereh Shokohi
Journal:  Curr Med Mycol       Date:  2019-03

5.  Granulomatous tracheo-bronchitis associated with Crohn's disease.

Authors:  Kai Xia; Jacqueline Wolf; Sonia Friedman; David L Carr-Locke
Journal:  MedGenMed       Date:  2004-02-20

6.  Tracheobronchial nodules and pulmonary infiltrates in a patient with Crohn's disease.

Authors:  De-Gan Lu; Xiao-Qing Ji; Qi Zhao; Cai-Qing Zhang; Zhen-Fang Li
Journal:  World J Gastroenterol       Date:  2012-10-21       Impact factor: 5.742

7.  Intestinally-restricted Janus Kinase inhibition: a potential approach to maximize the therapeutic index in inflammatory bowel disease therapy.

Authors:  David T Beattie; M Teresa Pulido-Rios; Fei Shen; Melissa Ho; Eva Situ; Pam R Tsuruda; Patrick Brassil; Melanie Kleinschek; Sharath Hegde
Journal:  J Inflamm (Lond)       Date:  2017-12-06       Impact factor: 4.981

8.  Immunosuppressive therapies adversely affect blood biochemical parameters in patients with inflammatory bowel disease: a meta-analysis.

Authors:  Xiaobing Wang; Ge Wang; Jian Shang; Huaqin Pan; Xin A Zhang; Feng Zhou
Journal:  J Int Med Res       Date:  2019-07-31       Impact factor: 1.671

9.  Response to hepatitis B vaccination in patients with inflammatory bowel disease: a prospective observational study in Korea.

Authors:  Ji Young Chang; Sung-Ae Jung; Chang Mo Moon; Seong-Eun Kim; Hye-Kyung Jung; Ki-Nam Shim
Journal:  Intest Res       Date:  2018-10-10

Review 10.  Detection of cytotoxic CD13-specific autoantibodies in sera from patients with ulcerative colitis and Crohn's disease.

Authors:  A Rahbar; L Boström; C Söderberg-Naucler
Journal:  J Autoimmun       Date:  2006-04-11       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.